Xilio Development
Price & Volume
Stats
See moreOpen | $0.83 |
Previous Close | $0.83 |
Day Range | $0.80-$0.83 |
52W Range | $0.61-$1.70 |
Market Cap | $43.6M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 243% |
Gross Profit (12 Mos) | $13M |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • 4 hours ago
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Xilio Development earnings missed by $0.06, revenue topped estimates
Yahoo Finance • 2 months ago
Xilio Therapeutics GAAP EPS of -$0.16 misses by $0.06
Yahoo Finance • 2 months ago
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
CFO | Mr. Christopher Frankenfield |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
